Related Experiment Video
Updated: Jan 20, 2026

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
Published on: September 19, 2019
Haemolytic uraemic syndrome associated with gemcitabine
Irene Moya-Horno1, Rosa Querol Niñerola, Teresa Bonfill Abella
1Medical Oncology Service, Hospital de Sabadell, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain.
Abstract:
Haemolytic uraemic syndrome (HUS) is a rare thromboembolic complication observed in patients with cancer. It is characterised by the clinical triad of acute renal failure, microangiopathic haemolytic anaemia and thrombocytopaenia. It may be associated with a variety of aetiologies, including chemotherapeutic agents such as mitomycin, cisplatin, bleomycin, 5-fluorouracil and, most recently, gemcitabine. We report a 70-year-old patient treated with gemcitabine who developed haemolytic uraemic syndrome.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Acute Coronary Syndrome I: Introduction
09:39Generation of Induced Pluripotent Stem Cells from Turner Syndrome (45XO) Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
05:12Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
08:31Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
08:26Measuring the 50% Haemolytic Complement (CH50) Activity of Serum

